CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination

Journal of Virology

Volumn 88, Issue 15, 2014, Pages 8349-8354

  Jost, Stephanie ^a   Tomezsko, Phillip John ^a   Rands, Keith ^a   Toth, Ildiko ^a   Lichterfeld, Mathias ^b   Gandhi, Rajesh Tim ^a,b   Altfeld, Marcus ^a,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 2;

ADAPTIVE IMMUNITY; ADJUVANT THERAPY; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BIOACCUMULATION; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ENZYME RECONSTITUTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION CONTROL; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; VACCINATION;

ADULT; AIDS VACCINES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; GENE PRODUCTS, TAT; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-2; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 84903908112     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00924-14     Document Type: Article

References (34)

1. + T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina. J. Immunol. 190:285-295. http://dx.doi.org/10.4049/jimmunol.1200861.
2. + T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model. J. Immunol. 189:1878-1885. http://dx.doi.org/10.4049/jimmunol.1201026.
3. He XS, Draghi M, Mahmood K, Holmes TH, Kemble GW, Dekker CL, Arvin AM, Parham P, Greenberg HB. 2004. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J. Clin. Investig. 114:1812-1819. http://dx.doi.org/10.1172/JCI22797.
4. Horowitz A, Newman KC, Evans JH, Korbel DS, Davis DM, Riley EM. 2010. Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J. Immunol. 184:6043-6052. http://dx.doi.org/10.4049/jimmunol.1000106.
5. + T cell-dependent activation of NK cells following vaccination. J. Immunol. 185: 2808-2818. http://dx.doi.org/10.4049/jimmunol.1000844.
6. Horowitz A, Hafalla JC, King E, Lusingu J, Dekker D, Leach A, Moris P, Cohen J, Vekemans J, Villafana T, Corran PH, Bejon P, Drakeley CJ, von Seidlein L, Riley EM. 2012. Antigen-specific IL-2 secretion correlates withNKcell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine. J. Immunol. 188:5054-5062. http://dx.doi.org/10.4049/jimmunol.1102710.
7. McCall MB, Roestenberg M, Ploemen I, Teirlinck A, Hopman J, de Mast Q, Dolo A, Doumbo OK, Luty A, van der Ven AJ, Hermsen CC, Sauerwein RW. 2010. Memory-like IFN-gamma response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum. Eur. J. Immunol. 40:3472-3477. http://dx.doi.org/10.1002/eji.201040587.
8. + T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 77:10900-10909. http://dx.doi.org/10.1128/JVI.77.20.10900-10909.2003.
9. + T cells endowed with proliferative capacity. J. Exp. Med. 198:1909-1922. http://dx.doi.org/10.1084/jem.20031598.
10. Robbins GK, Addo MM, Troung H, Rathod A, Habeeb K, Davis B, Heller H, Basgoz N, Walker BD, Rosenberg ES. 2003. Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization. AIDS 17:1121-1126. http://dx.doi.org/10.1097/00002030-200305230-00002.
11. + T cells. J. Exp. Med. 200:701-712. http://dx.doi.org/10.1084/jem.20041270.
12. Angel JB, Kumar A, Parato K, Filion LG, Diaz-Mitoma F, Daftarian P, Pham B, Sun E, Leonard JM, Cameron DW. 1998. Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J. Infect. Dis. 177:898-904. http://dx.doi.org/10.1086/515244.
13. Blankson JN, Gallant JE, Siliciano RF. 2001. Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution. J. Infect. Dis. 183:657-661. http://dx.doi.org/10.1086/318545.
14. Lisziewicz J, Rosenberg E, Lieberman J, Jessen H, Lopalco L, Siliciano R, Walker B, Lori F. 1999. Control of HIV despite the discontinuation of antiretroviral therapy. N. Engl. J. Med. 340:1683-1684. http://dx.doi.org/10.1056/NEJM199905273402114.
15. Iannello A, Debbeche O, Samarani S, Ahmad A. 2008. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. J. Leukoc. Biol. 84:1-26.
16. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Trowsdale J, Wilson M, O'Brien SJ, Carrington M. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31:429-434. http://dx.doi.org/10.1038/ng934.
17. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, Colombo S, Brown EE, Shupert WL, Phair J, Goedert JJ, Buchbinder S, Kirk GD, Telenti A, Connors M, O'Brien SJ, Walker BD, Parham P, Deeks SG, McVicar DW, Carrington M. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39:733-740. http://dx.doi.org/10.1038/ng2035.
18. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, Oniangue-Ndza C, Martin M, Li B, Khakoo SI, Carrington M, Allen TM, Altfeld M. 2011. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476:96-100. http://dx.doi.org/10.1038/nature10237.
19. Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, Streeck H, Waring M, Meier A, Brander C, Lifson JD, Allen TM, Carrington M, Altfeld M. 2007. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204:3027-3036. http://dx.doi.org/10.1084/jem.20070695.
20. Alter G, Rihn S, Walter K, Nolting A, Martin M, Rosenberg ES, Miller JS, Carrington M, Altfeld M. 2009. HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J. Virol. 83:6798-6805. http://dx.doi.org/10.1128/JVI.00256-09.
21. Boulet S, Kleyman M, Kim JY, Kamya P, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF. 2008. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS 22:1487-1491. http://dx.doi.org/10.1097/QAD.0b013e3282ffde7e.
22. Boulet S, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF. 2008. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 22:595-599. http://dx.doi.org/10.1097/QAD.0b013e3282f56b23.
23. O'Connell KA, Han Y, Williams TM, Siliciano RF, Blankson JN. 2009. Role of natural killer cells in a cohort of elite suppressors: low frequency of the protective KIR3DS1 allele and limited inhibition of human immunodeficiency virus type 1 replication in vitro. J. Virol. 83:5028-5034. http://dx.doi.org/10.1128/JVI.02551-08.
24. Parsons MS, Boulet S, Song R, Bruneau J, Shoukry NH, Routy JP, Tsoukas CM, Bernard NF. 2010. Mind the gap: lack of association between KIR3DL1*004/HLA-Bw4-induced natural killer cell function and protection from HIV infection. J. Infect. Dis. 202(Suppl 3):S356-S360. http://dx.doi.org/10.1086/655966.
25. + T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals. J. Acquir. Immune Defic. Syndr. 59:1-9. http://dx.doi.org/10.1097/QAI.0b013e3182373b77.
26. Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, Rathod A, Baker B, Trocha A, Rosenberg R, Mackey E, Ueda P, Lu Z, Cohen D, Wrin T, Petropoulos CJ, Rosenberg ES, Walker BD. 2008. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 197:563-571. http://dx.doi.org/10.1086/526786.
27. Harari A, Petitpierre S, Vallelian F, Pantaleo G. 2004. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103:966-972. http://dx.doi.org/10.1182/blood-2003-04-1203.
28. Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, Casazza JP, Koup RA, Picker LJ. 2001. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-11991. http://dx.doi.org/10.1128/JVI.75.24.11983-11991.2001.
29. + T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J. Virol. 81:13904-13915. http://dx.doi.org/10.1128/JVI.01401-07.
30. + T cell responses associated with control of viremia. Science 278:1447-1450. http://dx.doi.org/10.1126/science.278.5342.1447.
31. Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, Caligiuri MA. 2003. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101:3052-3057. http://dx.doi.org/10.1182/blood-2002-09-2876.
32. Trinchieri G. 1998. Immunobiology of interleukin-12. Immunol. Res. 17:269-278. http://dx.doi.org/10.1007/BF02786451.
33. Aste-Amezaga M, D'Andrea A, Kubin M, Trinchieri G. 1994. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell. Immunol. 156:480-492. http://dx.doi.org/10.1006/cimm.1994.1192.
34. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G. 1991. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879. http://dx.doi.org/10.1084/jem.173.4.869.